| abstract |
In this specification, a pharmaceutical composition for the treatment of wounds containing an epithelial growth factor having heat stability is disclosed in this specification. The pharmaceutical composition as one aspect of the present invention minimizes the thermal deformation of the epithelial cell growth factor, so that even when a small amount of epithelial growth factor is contained, the wound healing effect is excellent. In addition, since the composition has stability over a wide range of pH, it can be used for various types of skin such as weak acidity, weak acidity and the like. In addition, the epithelial growth factor contained in the composition can be maintained in a stable state for a long period of time at a high temperature, so that it is excellent in storage and distribution of the manufacturer and the utilization of the user. |